BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Sales Revenue by Similar Products (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Dec. 02, 2023	Dec. 03, 2022	Dec. 02, 2023	Dec. 03, 2022
Concentration Risk [Line Items]
Net sales and other revenue	$ 18,557.3	$ 18,154.9	$ 60,898.2	$ 59,384.6
Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 18,557.3	$ 18,154.9	$ 60,898.2	$ 59,384.6
Percentage of total net sales and other revenue	100.00%	100.00%	100.00%	100.00%
Non-perishables | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 9,242.8	$ 9,255.2	$ 30,566.5	$ 29,705.7
Percentage of total net sales and other revenue	49.80%	51.00%	50.20%	50.00%
Fresh | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 5,709.0	$ 5,762.6	$ 19,517.7	$ 19,588.6
Percentage of total net sales and other revenue	30.80%	31.70%	32.00%	33.00%
Pharmacy | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 2,282.8	$ 1,724.4	$ 6,323.9	$ 5,124.2
Percentage of total net sales and other revenue	12.30%	9.50%	10.40%	8.60%
Fuel | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 1,046.7	$ 1,111.1	$ 3,573.9	$ 3,968.6
Percentage of total net sales and other revenue	5.60%	6.10%	5.90%	6.70%
Other | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 276.0	$ 301.6	$ 916.2	$ 997.5
Percentage of total net sales and other revenue	1.50%	1.70%	1.50%	1.70%